Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy
- PMID: 15618539
- DOI: 10.1161/01.RES.0000154079.20681.B9
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy
Abstract
Evidence is emerging that systemic metabolic disturbances contribute to cardiac myocyte dysfunction and clinically apparent heart failure, independent of associated coronary artery disease. To test the hypothesis that perturbation of lipid homeostasis in cardiomyocytes contributes to cardiac dysfunction, we engineered transgenic mice with cardiac-specific overexpression of fatty acid transport protein 1 (FATP1) using the alpha-myosin heavy chain gene promoter. Two independent transgenic lines demonstrate 4-fold increased myocardial free fatty acid (FFA) uptake that is consistent with the known function of FATP1. Increased FFA uptake in this model likely contributes to early cardiomyocyte FFA accumulation (2-fold increased) and subsequent increased cardiac FFA metabolism (2-fold). By 3 months of age, transgenic mice have echocardiographic evidence of impaired left ventricular filling and biatrial enlargement, but preserved systolic function. Doppler tissue imaging and hemodynamic studies confirm that these mice have predominantly diastolic dysfunction. Furthermore, ambulatory ECG monitoring reveals prolonged QT(c) intervals, reflecting reductions in the densities of repolarizing, voltage-gated K+ currents in ventricular myocytes. Our results show that in the absence of systemic metabolic disturbances, such as diabetes or hyperlipidemia, perturbation of cardiomyocyte lipid homeostasis leads to cardiac dysfunction with pathophysiological findings similar to those in diabetic cardiomyopathy. Moreover, the MHC-FATP model supports a role for FATPs in FFA import into the heart in vivo.
Similar articles
-
Ca2+-independent alterations in diastolic sarcomere length and relaxation kinetics in a mouse model of lipotoxic diabetic cardiomyopathy.Circ Res. 2009 Jan 2;104(1):95-103. doi: 10.1161/CIRCRESAHA.108.186809. Epub 2008 Nov 20. Circ Res. 2009. PMID: 19023131
-
Genetic modification of the heart: transgenic modification of cardiac lipid and carbohydrate utilization.J Mol Cell Cardiol. 2005 Oct;39(4):581-93. doi: 10.1016/j.yjmcc.2005.07.005. J Mol Cell Cardiol. 2005. PMID: 16140322 Review.
-
Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.J Pharmacol Exp Ther. 2005 May;313(2):586-93. doi: 10.1124/jpet.104.080259. Epub 2005 Jan 25. J Pharmacol Exp Ther. 2005. PMID: 15671204
-
Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice.Exp Physiol. 2009 Feb;94(2):220-7. doi: 10.1113/expphysiol.2008.044800. Epub 2008 Oct 22. Exp Physiol. 2009. PMID: 18945756
-
Diabetes-related metabolic perturbations in cardiac myocyte.Diabetes Metab. 2008 Feb;34 Suppl 1:S3-9. doi: 10.1016/S1262-3636(08)70096-X. Diabetes Metab. 2008. PMID: 18358420 Review.
Cited by
-
Metabolic remodelling in atrial fibrillation: manifestations, mechanisms and clinical implications.Nat Rev Cardiol. 2024 May 30. doi: 10.1038/s41569-024-01038-6. Online ahead of print. Nat Rev Cardiol. 2024. PMID: 38816507 Review.
-
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.J Pharm Pharm Sci. 2024 Apr 19;27:12568. doi: 10.3389/jpps.2024.12568. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 38706718 Free PMC article. Review.
-
Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.Cardiovasc Diabetol. 2024 Apr 25;23(1):139. doi: 10.1186/s12933-024-02233-y. Cardiovasc Diabetol. 2024. PMID: 38664790 Free PMC article.
-
Molecular mechanisms of metabolic dysregulation in diabetic cardiomyopathy.Front Cardiovasc Med. 2024 Mar 25;11:1375400. doi: 10.3389/fcvm.2024.1375400. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38596692 Free PMC article. Review.
-
Current status and emerging trends of cardiac metabolism from the past 20 years: A bibliometric study.Heliyon. 2023 Nov 8;9(11):e21952. doi: 10.1016/j.heliyon.2023.e21952. eCollection 2023 Nov. Heliyon. 2023. PMID: 38045208 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials